Madrigal Shows Confidence As It Awaits FDA’s March Decision On Resmetirom

 
• By Joseph Haas
  
2023 AASLD
At AASLD in Boston, it seemed fair to view Madrigal as the “belle of the ball.” • Source: Scrip
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip